产品标题 产品货号 产品规格 厂家
Cmtm5 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5035261 kitORIGENE TECHNOLOGIES
Cmtm6 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5035271 kitORIGENE TECHNOLOGIES
Cmtm7 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5035281 kitORIGENE TECHNOLOGIES
Cmtm8 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5035291 kitORIGENE TECHNOLOGIES
CMTM4 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH31079310 ugORIGENE TECHNOLOGIES
CMTM6 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH30106110 ugORIGENE TECHNOLOGIES
CMTM7 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH31839510 ugORIGENE TECHNOLOGIES
CMTR1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4057621 kitORIGENE TECHNOLOGIES
Cmtr1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5035301 kitORIGENE TECHNOLOGIES
CMTR2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4061091 kitORIGENE TECHNOLOGIES
Cmtr2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5035311 kitORIGENE TECHNOLOGIES
Human Breast; Adenosis of breast, sclerosing from ORIGENE TECHNOLOGIESCS7062805x5umORIGENE TECHNOLOGIES
CMV IgG ELISA Kit from ORIGENE TECHNOLOGIESEA10106296-well strip plateORIGENE TECHNOLOGIES
Human Breast; Adenosis of breast, sclerosing from ORIGENE TECHNOLOGIESCS8017245x5umORIGENE TECHNOLOGIES
Human Breast; Adenosis of breast, sclerosing from ORIGENE TECHNOLOGIESCS8124285x5umORIGENE TECHNOLOGIES
Human Breast; Adenosis of breast, sclerosing from ORIGENE TECHNOLOGIESCS8052895x5umORIGENE TECHNOLOGIES
Human Breast; Adenosis of breast, sclerosing from ORIGENE TECHNOLOGIESCS5039195x5umORIGENE TECHNOLOGIES
Human Breast; Adenosis of breast, sclerosing from ORIGENE TECHNOLOGIESCS5039215x5umORIGENE TECHNOLOGIES
Human Breast; Adenosis of breast, sclerosing from ORIGENE TECHNOLOGIESCS5168425x5umORIGENE TECHNOLOGIES
Human Breast; Adenosis of breast, sclerosing from ORIGENE TECHNOLOGIESCS5223435x5umORIGENE TECHNOLOGIES
Human Breast; Adenosis of breast, sclerosing from ORIGENE TECHNOLOGIESCS6039115x5umORIGENE TECHNOLOGIES
Human Breast; Adenosis of breast, sclerosing from ORIGENE TECHNOLOGIESCS6445205x5umORIGENE TECHNOLOGIES
Human Breast; Adenosis of breast, sclerosing from ORIGENE TECHNOLOGIESCS6445215x5umORIGENE TECHNOLOGIES
Human Breast; Adenosis of breast, sclerosing from ORIGENE TECHNOLOGIESCS6445225x5umORIGENE TECHNOLOGIES
Human Breast; Apocrine metaplasia of breast from ORIGENE TECHNOLOGIESCS7086315x5umORIGENE TECHNOLOGIES
Human Breast; Apocrine metaplasia of breast from ORIGENE TECHNOLOGIESCS7087735x5umORIGENE TECHNOLOGIES
Human Breast; Apocrine metaplasia of breast from ORIGENE TECHNOLOGIESCS7105935x5umORIGENE TECHNOLOGIES
Human Breast; Apocrine metaplasia of breast from ORIGENE TECHNOLOGIESCS7168165x5umORIGENE TECHNOLOGIES
Human Breast; Apocrine metaplasia of breast from ORIGENE TECHNOLOGIESCS8048815x5umORIGENE TECHNOLOGIES
Human Breast; Apocrine metaplasia of breast from ORIGENE TECHNOLOGIESCS8111085x5umORIGENE TECHNOLOGIES
Human Breast; Apocrine metaplasia of breast from ORIGENE TECHNOLOGIESCS5283745x5umORIGENE TECHNOLOGIES
Human Breast; Apocrine metaplasia of breast from ORIGENE TECHNOLOGIESCS5361775x5umORIGENE TECHNOLOGIES
Human Breast; Apocrine metaplasia of breast from ORIGENE TECHNOLOGIESCS6029665x5umORIGENE TECHNOLOGIES
Human Breast; Apocrine metaplasia of breast from ORIGENE TECHNOLOGIESCS6062545x5umORIGENE TECHNOLOGIES
Human Breast; Apocrine metaplasia of breast from ORIGENE TECHNOLOGIESCS6090575x5umORIGENE TECHNOLOGIES
Human Breast; Biopsy cavity of breast from ORIGENE TECHNOLOGIESCS8117535x5umORIGENE TECHNOLOGIES
Human Breast; Apocrine metaplasia of breast, papillary from ORIGENE TECHNOLOGIESCS8006255x5umORIGENE TECHNOLOGIES
Cytochrome P450, family 2, subfamily D, polypeptide 6 (CYP2D6), transcript variant 1 from ORIGENE TECHNOLOGIESLY424921100 ugORIGENE TECHNOLOGIES
Cytochrome P450, family 2, subfamily D, polypeptide 6 (CYP2D6), transcript variant 2 from ORIGENE TECHNOLOGIESLY422597100 ugORIGENE TECHNOLOGIES
Cytochrome P450, family 2, subfamily E, polypeptide 1 (CYP2E1) from ORIGENE TECHNOLOGIESLY400264100 ugORIGENE TECHNOLOGIES
Cytochrome P450, family 4, subfamily F, polypeptide 12 (CYP4F12) from ORIGENE TECHNOLOGIESLY402967100 ugORIGENE TECHNOLOGIES
Cytochrome P450, family 4, subfamily F, polypeptide 22 (CYP4F22) from ORIGENE TECHNOLOGIESLY406600100 ugORIGENE TECHNOLOGIES
Cytochrome P450, family 4, subfamily F, polypeptide 8 (CYP4F8) from ORIGENE TECHNOLOGIESLY416092100 ugORIGENE TECHNOLOGIES
Cytochrome P450, family 4, subfamily F, polypeptide 11 (CYP4F11), transcript variant 1 from ORIGENE TECHNOLOGIESLY412026100 ugORIGENE TECHNOLOGIES
Cytochrome P450, family 4, subfamily F, polypeptide 11 (CYP4F11), transcript variant 2 from ORIGENE TECHNOLOGIESLY427033100 ugORIGENE TECHNOLOGIES
Cytochrome P450, family 2, subfamily J, polypeptide 2 (CYP2J2) from ORIGENE TECHNOLOGIESLY424525100 ugORIGENE TECHNOLOGIES
Cytochrome P450, family 2, subfamily R, polypeptide 1 (CYP2R1) from ORIGENE TECHNOLOGIESLY411259100 ugORIGENE TECHNOLOGIES
Cytochrome P450, family 2, subfamily S, polypeptide 1 (CYP2S1) from ORIGENE TECHNOLOGIESLY410796100 ugORIGENE TECHNOLOGIES
Cytochrome P450, family 2, subfamily W, polypeptide 1 (CYP2W1) from ORIGENE TECHNOLOGIESLY413554100 ugORIGENE TECHNOLOGIES
Cytochrome P450, family 4, subfamily X, polypeptide 1 (CYP4X1) from ORIGENE TECHNOLOGIESLY406024100 ugORIGENE TECHNOLOGIES
 |< < 2206 2207 2208 2209 2210 2211 2212 2213 2214 > >| 第 2213/6274 页